13.03.2020 • NewsDede WillamsBiogen

Biogen and Vir in COVID-19 Collaboration

Biogen and Vir in COVID-19 Collaboration (c) Steve Debenport/Getty Images
Biogen and Vir in COVID-19 Collaboration (c) Steve Debenport/Getty Images

Biogen and Vir Biotechnology, the new company of its former Biogen CEO George Scangos, have signed a letter of intent to develop and manufacture a new antibody to fight COVID-19. The companies said their collaboration is still subject to final agreements, but due to the urgency of the crisis they have already started work.

Scangos is also in charge of the Biotechnology Industry Organization's coronavirus response.

Under the terms of the envisioned agreement, Biogen will have responsibility for working out cell line development, process development and handling clinical manufacturing for Vir's monoclonal antibodies.

Vir said the antibodies it has discovered bind to the novel coronavirus, and it is now testing whether they can treat or prevent the infection.

As Biogen is one of the global leaders in cell line and process development for advanced biologics, tapping into its capabilities will provide Vir with a US base for supply and manufacture of antibody therapies, Scangos said in a statement.

According to trade journal Fierce Pharma, Vir recently expanded its RNAi partnership with Alnylam to explore whether the technology might be able to address the novel coronavirus. Those companies had entered an infectious disease collaboration back in 2017.

Ironically, a Biogen corporate meeting in late February is now linked to more than 80 cases of the new virus strain.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.